These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 28541728

  • 21. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK, Beste C.
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract] [Full Text] [Related]

  • 22. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
    London ED.
    Adv Pharmacol; 2016 Jul; 76():67-84. PubMed ID: 27288074
    [Abstract] [Full Text] [Related]

  • 23. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R, Rodler R, Schmeisser U, Steinmann J, Wolfersdorf M.
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [Abstract] [Full Text] [Related]

  • 24. Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review.
    Paulus MP, Stewart JL.
    JAMA Psychiatry; 2020 Sep 01; 77(9):959-966. PubMed ID: 32267484
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.
    Arch Gen Psychiatry; 2005 Oct 01; 62(10):1148-56. PubMed ID: 16203960
    [Abstract] [Full Text] [Related]

  • 30. BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
    Manning EE, Halberstadt AL, van den Buuse M.
    Int J Neuropsychopharmacol; 2016 Apr 01; 19(4):. PubMed ID: 26453694
    [Abstract] [Full Text] [Related]

  • 31. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, Methamphetamine Treatment Project Corporate Authors.
    J Subst Abuse Treat; 2008 Dec 01; 35(4):445-50. PubMed ID: 18294802
    [Abstract] [Full Text] [Related]

  • 32. Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use.
    Flavel SC, White JM, Todd G.
    J Appl Physiol (1985); 2012 Nov 01; 113(9):1486-94. PubMed ID: 22961269
    [Abstract] [Full Text] [Related]

  • 33. The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa.
    Berg MK, Hobkirk AL, Joska JA, Meade CS.
    Psychol Trauma; 2017 Jul 01; 9(4):493-499. PubMed ID: 27710005
    [Abstract] [Full Text] [Related]

  • 34. Information from your family doctor. Meth abuse: what you should know.
    American Academy of Family Physicians.
    Am Fam Physician; 2007 Oct 15; 76(8):1175-6. PubMed ID: 17990841
    [No Abstract] [Full Text] [Related]

  • 35. [Legal measures in illicit drug detection: Management of urine tests in psychiatric treatment of methamphetamine dependence patients].
    Matsumoto T.
    Chudoku Kenkyu; 2011 Sep 15; 24(3):193-7. PubMed ID: 21950017
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N, Takahashi K, Nishimura Y, Koike S, Ishii-Takahashi A, Sakakibara E, Satomura Y, Kinoshita A, Takizawa R, Kawasaki S, Nakakita M, Ohtani T, Okazaki Y, Kasai K.
    Addict Biol; 2016 Mar 15; 21(2):489-503. PubMed ID: 25619621
    [Abstract] [Full Text] [Related]

  • 38. Key differences in treatment-seeking stimulant users attending a specialised treatment service: a means of early intervention?
    Arunogiri S, Petrie M, Sharkey M, Lubman DI.
    Australas Psychiatry; 2017 Jun 15; 25(3):246-249. PubMed ID: 28068828
    [Abstract] [Full Text] [Related]

  • 39. [Establishment and evaluation of animal model with methamphetamine poisoning].
    Xu J, Zhou XL, Zhang H, Deng C, Zhang Y, Li Z.
    Fa Yi Xue Za Zhi; 2009 Aug 15; 25(4):282-5. PubMed ID: 19788080
    [Abstract] [Full Text] [Related]

  • 40. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P, Mravcik V, Lopez D, Klempova D.
    Drug Alcohol Rev; 2008 May 15; 27(3):236-42. PubMed ID: 18368604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.